For all breast cancer tissues from deletion carriers, the ratios were similar to those of the controls heterozygous for the variant (all ratios > 0.43), suggesting that the wild-type GEN1 allele was retained in all cancers (Figure 1). Here, GEN1 is linked to breast cancer.